These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24271191)

  • 1. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
    Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
    Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
    Grams ME; Juraschek SP; Selvin E; Foster MC; Inker LA; Eckfeldt JH; Levey AS; Coresh J
    Am J Kidney Dis; 2013 Aug; 62(2):253-60. PubMed ID: 23619125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.
    Fan L; Inker LA; Rossert J; Froissart M; Rossing P; Mauer M; Levey AS
    Nephrol Dial Transplant; 2014 Jun; 29(6):1195-203. PubMed ID: 24449101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
    Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
    Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of chronic kidney disease epidemiology collaboration equations in a Chinese population.
    Zhang M; Chen Y; Tang L; Zhang J; Liu S; Wang S; Wei R; Zhou J; Cao X; Zhang W; Zhang J; Yang Y; Cai G; Sun X; Chen X
    Nephrol Dial Transplant; 2014 Mar; 29(3):580-6. PubMed ID: 24335503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
    Hundemer GL; White CA; Norman PA; Knoll GA; Tangri N; Sood MM; Hiremath S; Burns KD; McCudden C; Akbari A
    Am J Kidney Dis; 2022 Oct; 80(4):462-472.e1. PubMed ID: 35588905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
    Husain SA; Willey JZ; Park Moon Y; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
    PLoS One; 2018; 13(11):e0206839. PubMed ID: 30427947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
    JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geriatric assessment of estimated glomerular filtration rate: a cross-sectional study.
    Yamaguchi Y; Itabashi M; Yumura W; Takei T
    Clin Exp Nephrol; 2020 Mar; 24(3):216-224. PubMed ID: 31617027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
    Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Estimated Glomerular Filtration Rate with Both Serum Creatinine and Cystatin C (eGFRcr-cys) versus Single Analyte (eGFRcr or eGFRcys) Using CKD-EPI and MDRD Equations in Tertiary Care Hospital Settings.
    Khalid UB; Haroon ZH; Aamir M; Ain QU; Mansoor K; Jaffar SR
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):701-706. PubMed ID: 32811598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Ide H; Iwase M; Fujii H; Ohkuma T; Kaizu S; Jodai T; Kikuchi Y; Idewaki Y; Sumi A; Nakamura U; Kitazono T
    Clin Exp Nephrol; 2017 Jun; 21(3):383-390. PubMed ID: 27339449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CKD Prevalence and Incidence in Older Adults Using Estimated GFR With Different Filtration Markers: The Atherosclerosis Risk in Communities Study.
    Flaherty CM; Surapaneni A; Seegmiller JC; Coresh J; Grams ME; Ballew SH
    Kidney Med; 2024 Oct; 6(10):100893. PubMed ID: 39319210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.
    Willey JZ; Moon YP; Husain SA; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
    PLoS One; 2020; 15(1):e0226509. PubMed ID: 31940363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR.
    Wang Y; Adingwupu OM; Shlipak MG; Doria A; Estrella MM; Froissart M; Gudnason V; Grubb A; Kalil R; Mauer M; Rossing P; Seegmiller J; Coresh J; Levey AS; Inker LA
    Kidney Med; 2023 Oct; 5(10):100710. PubMed ID: 37753251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women.
    Driver TH; Scherzer R; Peralta CA; Tien PC; Estrella MM; Parikh CR; Butch AW; Anastos K; Cohen MH; Nowicki M; Sharma A; Young MA; Abraham A; Shlipak MG
    AIDS; 2013 Sep; 27(14):2291-9. PubMed ID: 23669156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.